Number of the records: 1  

NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy

  1. 1.
    Kafkova, L. R. - Mierzwicka, Joanna Maria - Chakraborty, P. - Jakubec, P. - Fischer, O. - Škarda, J. - Malý, Petr - Raška, M.
    NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy.
    Frontiers in Immunology. Roč. 15, FEB 7 2024 (2024), č. článku 1342086. ISSN 1664-3224. E-ISSN 1664-3224
    OECD category: Immunology
    Impact factor: 5.7, year: 2023 ; AIS: 1.693, rok: 2023
    Method of publishing: Open access
    Result website:
    https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1342086/fullDOI: https://doi.org/10.3389/fimmu.2024.1342086
    https://hdl.handle.net/11104/0353420
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.